CIK 0001534120 · Non-accelerated filer<br>Smaller reporting company
Avalo Therapeutics, Inc.
Sign in to watch- Ticker
- AVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450705648
- Phone
- 410-522-8707
- Business address
- 1500 LIBERTY RIDGE DRIVE, SUITE 321, WAYNE, PA, 19087
- Former names
- Cerecor Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,865,893
- in 5 filings, $1.9M under 10b5-1 plans
Net −$1,865,893. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-31 | Jain Rita Director | Grant or award · Stock Option (Right to Buy) | +1,043 | $14.74 | $15K | 1,043 |
| 2025-12-10 | Doyle Mittie Chief Medical Officer | Shares withheld for taxes | −1,013 | $4.10 | $4K | 3,622 |
| 2025-12-10 | Riley Jennifer Chief Strategy Officer | Shares withheld for taxes | −637 | $4.10 | $3K | 2,655 |
| 2025-12-10 | VARKI PAUL Chief Legal Officer | Shares withheld for taxes | −1,016 | $4.10 | $4K | 3,634 |
| 2025-12-10 | Sullivan Christopher Ryan Chief Financial Officer | Shares withheld for taxes | −155 | $4.10 | $636 | 17,338 |
| 2025-11-14 | Goldman Jonathan Director | Sale | −3,167 | $14.30 | $45K | 0 |
| 2025-11-14 | Goldman Jonathan Director | Option exercise | +8,200 | $9.88 | $81K | 8,200 |
| 2025-11-14 | Goldman Jonathan Director | Sale | −8,200 | $14.35 | $118K | 0 |
| 2025-11-14 | Goldman Jonathan Director | Option exercise · Stock Option (Right to Buy) | −8,200 | 16,400 | ||
| 2025-10-01 | Boyd Taylor Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +275,000 | 275,000 | ||
| 2025-10-01 | Lind Kevin Robert Director | Grant or award · Stock Option (Right to Buy) | +40,200 | 40,200 | ||
| 2025-09-30 | Jain Rita Director | Grant or award · Stock Option (Right to Buy) | +1,572 | 1,572 | ||
| 2025-06-17 | Truex Samantha Director | Grant or award · Stock Option (Right to Buy) | +20,100 | 20,100 | ||
| 2025-06-17 | Chan Mitchell Director | Grant or award · Stock Option (Right to Buy) | +20,100 | 20,100 | ||
| 2025-06-17 | Goldman Jonathan Director | Grant or award · Stock Option (Right to Buy) | +20,100 | 20,100 | ||
| 2025-06-17 | KAPLAN GILLA Director | Grant or award · Stock Option (Right to Buy) | +20,100 | 20,100 | ||
| 2025-06-17 | KANTOFF AARON Director | Grant or award · Stock Option (Right to Buy) | +20,100 | 20,100 | ||
| 2025-06-17 | Heffernan Michael Thomas Director | Grant or award · Stock Option (Right to Buy) | +29,500 | 29,500 | ||
| 2025-06-17 | Almenoff June Sherie Director | Grant or award · Stock Option (Right to Buy) | +20,100 | 20,100 | ||
| 2025-06-17 | Jain Rita Director | Grant or award · Stock Option (Right to Buy) | +40,200 | 40,200 |
Page 8 of 11 · 202 trades